Oases
Sharpsight Limited
Sharpsight is a Hong Kong-based technology start-up dedicated to providing intelligent products and solutions for the rehabilitation and elderly care sectors. Our “masquer” product series is designed for professional institutions and targets patients with neurological disorders, such as facial paralysis, and hand and limb dysfunction.
Taron Solutions Limited
Taron Solutions is the only contract development and manufacturing organisation specialising in biologics that operates in Hong Kong. Taron’s strengths lie in the expertise of its team in translational research, formulation, process and QC method development, as well as international cGMP manufacturing and regulatory experience. Taron supports research institutes and biotech companies to accelerate their drug product development towards clinical studies.
E3A Healthcare Pte Limited
Founded in 2019, E3A Healthcare is a medical device company specialising in the development of innovative solutions for newborn and women’s healthcare. The company’s initial focus is on newborn jaundice monitoring. Newborn jaundice is a common disease affecting over 85% of Asian babies. Without timely treatment, it may lead to irreversible neural damage and disability. The high cost of monitoring devices has resulted in treatment remaining inaccessible for many families.
Tolo Digitech Limited
Tolo Digitech is the first spin-off of Laboratory of AI-Powered Financial Technologies Limited (AIFT), which is one of the InnoHK research centres. It provides a business ecosystem platform for stakeholders in the value chain of cross-border e-commerce finance, including banks, and logistics and payment firms.
Glassbox AI
Glassbox AI, with the support of HKSTP and HKAI Lab, is an innovative start-up providing Explainable AI services. The company’s objective is to address the shortcomings of black box AI systems, which are known for their lack of transparency and ethical concerns. Glassbox AI offers enhanced transparency, bias mitigation and accountability, enabling businesses, especially those in highly regulated sectors, to build trust and ensure fair and ethical AI implementation.